Answers are grounded in this paper and cite their sources.
Obesity is on the rise and is fast becoming a major modifiable risk factor responsible for leading noncommunicable diseases and deaths.Increasingly, primary care physicians will be exposed to patients with obesity-related diseases.Beyond type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovarian syndrome (PCOS) are two other conditions that are common.In this article, we explore the underlying associations of MASLD and PCOS with insulin resistance and offer some practical advice on screening and management of both conditions.
No takes yet. Share an insight, caveat, or question.
Yingshan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: